Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

152
 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
07/28/2014 07/29/2014 07/30/2014 07/31/2014 08/01/2014 Date
254 256.5 257.5 257.9 251.2 Last
1320169 1585593 1737287 2695879 2747287 Volume
+0.04% +0.98% +0.39% +0.16% -2.60% Change
Company
Novo Nordisk AS is engaged in the development, manufacture, and marketing of pharmaceutical products. It operates through the Diabetes Care and Biopharmaceuticals segments. The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas of... 
Sector
Pharmaceuticals
Calendar
08/07Earnings Release
Surperformance© rating of Novo Nordisk A/S
Trading Rating : Investor Rating :
More about the company
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Financials ( DKK)
Sales 2014 88 019 M
EBIT 2014 33 420 M
Net income 2014 26 573 M
Finance 2014 2 432 M
Yield 2014 1,89%
Sales 2015 96 440 M
EBIT 2015 37 678 M
Net income 2015 29 625 M
Finance 2015 1 787 M
Yield 2015 2,15%
PER 2014 24,73
PER 2015 21,75
EV / Sales 2014 6,00x
EV / Sales 2015 5,48x
Capitalization 530 676 M
More Financials
Latest news on NOVO NORDISK A/S
1d ago NOVO NORDISK A/S : Team Novo Nordisk to race in Tour of Denmark 2014
2d ago NOVO NORDISK A/S : Trademark Application for "SAXENDA" Filed by Novo Nordisk A/S
2d ago NOVO NORDISK A/S : Trademark Application for "VICSATIA" Filed
2d ago NOVO NORDISK A/S : Trademark Application for "ONLEED" Filed
2d ago NOVO NORDISK A/S : An Application for the Trademark "SAXORA" Has Been Filed by N..
2d ago NOVO NORDISK A/S : An Application for the Trademark "NEXSPART" Has Been Filed by..
3d ago NOVO NORDISK A/S : Studies from Novo Nordisk Add New Findings in the Area of Dia..
4d ago NOVO NORDISK A/S : Share repurchase programme
5d ago NOVO NORDISK A/S : Share repurchase programme
5d ago Novo Nordisk A/S - Share repurchase programme
5d ago NOVO NORDISK A/S : receives positive opinion on Xultophy (IDegLira) from the Eur..
07/25 NOVO NORDISK A/S : receives positive opinion on Xultophy® (IDegLira) from the Eu..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
Novo Nordisk A_S : Income Statement Evolution
More Financials
EPS Revisions
Novo Nordisk A_S : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF